Is Active Surveillance the Right Course For Men with Prostate Cancer?
Prostate Cancer

Is Active Surveillance the Right Course For Men with Prostate Cancer?

Prostate-specific antigen (PSA) testing of middle-age men to screen for prostate cancer has led to more cases being detected at an early stage.  The common occurrence of prostate cancer indicates that many of these men will die with prostate cancer rather than of the disease. “We recognize that anywhere from 30 to 50 percent of…

Is Surgery Better Than Hormone Therapy for Prostate Cancer
Prostate Cancer

Is Surgery Better Than Hormone Therapy for Prostate Cancer

A new study out of South Korea has shown that surgery is better than hormone therapy when treating prostate cancer. In this comparison of surgery and hormone therapy, the researchers found that men who underwent prostatectomy had a higher survival rate than those who had hormone or androgen deprivation therapy. Treatment options for prostate cancer…

Xtandi (Enzalutamide): How Much Does a Xtandi Prescription Cost?
Prostate Cancer

Xtandi (Enzalutamide): How Much Does a Xtandi Prescription Cost?

Xtandi (Enzalutamide): How Much Does a Xtandi Prescription Cost? The cost of Xtandi (enzalutamide) may be one factor that men might use to compare medications or make medical decisions for late-stage prostate cancer. Xtandi is a drug used to treat hormone-resistant prostate cancer that has metastasized or spread to other areas of the body. Monthly…

Breakthrough Prostate Cancer Treatment Most Promising in 15 Years
Prostate Cancer

Breakthrough Prostate Cancer Treatment Most Promising in 15 Years

Researchers in the United Kingdom have announced what they believe is the most promising new treatment for prostate cancer in 15 years. Known as PSMA (prostate specific membrane antigen) radiotherapy, it could extend the lives of many men who are living with advanced prostate cancer who have run out of treatment options. This “game changing”…